Weight Loss Jabs Reverse Arthritis Damage?

Weight loss medications containing semaglutide may offer significant benefits for arthritis sufferers, potentially reversing joint damage beyond just facilitating weight loss. Researchers have found that this drug can slow the progression of osteoarthritis and even repair damage to cartilage.

Studies conducted on mice revealed that semaglutide influences the metabolism of cartilage cells. This intervention led to reduced pain, slower cartilage deterioration, and fewer bone spurs in affected joints. Notably, these positive effects were observed even in mice that did not lose weight, suggesting a mechanism separate from fat reduction.

Further investigation involving 20 human participants, aged 50 to 75, who were obese and had osteoarthritis, yielded encouraging results. Those treated with semaglutide alongside a joint-lubricating agent reported less pain and better knee function after 24 weeks. MRI analyses confirmed recent cartilage growth and increased cartilage thickness.

While these findings suggest GLP-1 drugs may have therapeutic applications beyond weight management, the researchers urge caution. The small sample size of the human study necessitates further validation through larger clinical trials to confirm these protective effects on human knee joints.